期刊文献+

左乙拉西坦、丙戊酸钠、苯巴比妥预防大鼠反复热性惊厥疗效观察 被引量:6

Prophylactic efficacy of levetiracetam,valproate or phenobarbital on febrile convulsions in rats
原文传递
导出
摘要 目的比较左乙拉西坦、丙戊酸钠、苯巴比妥对大鼠反复热性惊厥的预防作用的差异,指导临床选药。方法 60只Wistar大鼠,随机分为4组,分别每日灌服左乙拉西坦(200mg/kg)、丙戊酸钠(250mg/kg)、苯巴比妥(30mg/kg)及生理盐水(8mL/kg)。连续灌服5d后,用热水浴(45℃)诱导热性惊厥,观察其热性惊厥潜伏期、惊厥持续时间、惊厥严重程度改变情况。结果大鼠用药后,3个药物干预组惊厥潜伏期延长、惊厥持续时间缩短,惊厥严重程度也明显减轻,与对照组比较差异有统计学意义(P<0.05或0.01),其中苯巴比妥组惊厥持续时间最短,惊厥严重程度最轻;左乙拉西坦组与丙戊酸钠组差异无统计学意义。结论左乙拉西坦与丙戊酸钠、苯巴比妥比较均能有效预防大鼠反复热性惊厥,其中苯巴比妥疗效较好,左乙拉西坦与丙戊酸钠疗效无差异。 Objective To study and compare the prophylatic efficacy of levetiracetam,valproate and phenobarbital on febrile convulsions in rats.Methods Sixty Wistar rats were randomly administered with levetiracetam(200 mg /kg),valproate(250 mg /kg),phenobarbital(30 mg /kg) or normal saline(8 ml /kg) for 5 days.Five days later,febrile convulsions were induced by hyperthermal bath(45℃).The latency,duration and the severity of seizures were observed.Results In all the three drug-treated groups,the latency was significantly prolonged,and the duration and the severity of seizures were notably reduced compared with the saline group(P〈0.05 or 0.01).The phenobarbital group had the shortest duration of seizures and the least severe seizures among the three drug-treated groups.There were no significant differences between the levetiracetam and valproate groups.Conclusions Continuous administration of levetiracetam,valproate or phenobarbital is effective in preventing recurrent febrile convulsions in rats.Phenobarbital appears to be more effective than levetiracetam and valproate.There were no significant differences in the prophylactic efficacy between levetiracetam and valproate.
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2010年第7期573-575,共3页 Chinese Journal of Contemporary Pediatrics
关键词 左乙拉西坦 热性惊厥 预防作用 大鼠 Levetiracetam Febrile convulsion Prophylatic efficacy Rats
  • 相关文献

参考文献13

  • 1常杏芝,秦炯,吴希如.幼年大鼠反复热性惊厥脑损伤的研究[J].中国当代儿科杂志,2002,4(6):439-442. 被引量:28
  • 2黄志,李娟.三种抗惊厥药物预防动物热性惊厥的比较研究[J].华南国防医学杂志,2006,20(2):12-14. 被引量:2
  • 3黄志,蔡方成,张晓萍.妥泰预防热性惊厥的临床及实验研究[J].第三军医大学学报,2004,26(2):155-158. 被引量:9
  • 4程敏,黄志,李思秀.左乙拉西坦预防动物热性惊厥的实验研究[J].儿科药学杂志,2009,15(4):16-18. 被引量:9
  • 5Jiang W, Duong TM, Lanerolle NC. The neuropathology of hyperthermic seizures in the rats[J]. Epilepsia, 1999, 40(1 ) :5-19.
  • 6Patsalos PN. Pharmacokinetic profile of levetiracetam : toward ideal characteristics [ J]. Pharmacol Ther, 2000, 85 (2):77-85.
  • 7Tong X, Patsalos PN. A microdialysis study of the novel antiepileptic drug levetiracetam: extracellular pharmacokinetics and effect on taurine in rat brain [J]. Br J Pharmacol, 2001 , 133(6) :867- 874.
  • 8Brockmoller J, Thomsen T, Wittstock M, Coupez R, Lochs H, Roots I. Pharmacokinetics of levitiracetam in patients with moderate to severe liver cirrhosis ( Child-Pugh classes A. B and C ) : characterization by dynamic liver function tests [J]. Clin Pharmacol Ther, 2005, 77 ( 6 ) :529-541.
  • 9Zona C, Niespodziany I, Marchetti C, Klitgaard H, Bernardi G, Margineanu DG. Levitiracetam does not modulate neuronal voltagegated Na^+ and T-type Ca^2+ currents [J]. Seizure, 2001, 10 (4) :279-286.
  • 10Klitgaard H. Levetiracetam: the preclinical profile of a new class of antiepileptic drugs? [J]. Epilepsia, 2001, 42 (Suppl 4) : 13- 18.

二级参考文献18

  • 1黄志,程敏,陈琼.妥泰预防儿童偏头痛发作的临床研究[J].重庆医学,2005,34(5):706-707. 被引量:7
  • 2黄志,李娟.三种抗惊厥药物预防动物热性惊厥的比较研究[J].华南国防医学杂志,2006,20(2):12-14. 被引量:2
  • 3[2]Jiang W,Duong TM,Lanerolle NC.The neuropathology of hyperthermic seizures in the rats.Epilepsia,1999,40(1):5 ~ 19
  • 4[4]Waruiru C,Appleton R.Febrile seizures:an update.Archdis childhood,2004,89 (8):751-756
  • 5[5]Champi C,Yocum G.Managing febrile seizures in children.Dimensions Crit Care Nursing,2001,20 (5):2 ~ 7
  • 6[8]White HS.Molecular pharmacology of topiramate:managing seizures and preventing migraine.Headache,2005,45 (suppl 1):48 ~56
  • 7Dube C, Chen K, Eghbal-Ahmadi M, et al. Prolonged febrile seizures in the immature rat model enhance hippocampal excitability long term [J]. Ann Neurol, 2000, 47(3): 336-344.
  • 8Morris R. Developments of a water-maze procedure for studying spatial learning in the rat [J]. J Neuro Sci Methods, 1984, 11(1): 47-60.
  • 9Jiang W, Duong TM, de Lanerolle NC. Neuropathology of Hyperthermic seizures in the rat [J]. Epilepsia, 1999, 40(1): 5-19.
  • 10Holmes GL, Thompson JL, Bates T, et al. Detrimental effects of frequent seizures on learning, memory, and behavior: a study using the pubescent genetically epilepsy-prone rat [J]. Ann Neurol, 1990, 27(1): 24-32.

共引文献41

同被引文献31

  • 1朱乾乾,王丽君,吕娟,郝云鹏,陈银波,梁东.左乙拉西坦预防儿童热性惊厥的临床研究及随访[J].环球中医药,2013,6(S2):105-106. 被引量:7
  • 2张茜,薛茜.浅谈系统评价常见的偏倚[J].循证医学,2006,6(2):105-108. 被引量:36
  • 3Simon D Shorvon,Emilio,Perucca,David,R.Fish,W.Edwin Dodson.The Treatment of Epilepsy,2nd edition[]..2005
  • 4Panayiotopoulos CP.Reflex seizures and reflex epilepsies[].The epilepsies:seizuressyndromes and management.2005
  • 5Gibbs S, Chattopadhyaya B, Desgent S, et al. Long-term consequences of a prolonged febrile seizure in a dual pathology model[J]. Neurobiol Dis, 2011, 43(2): 312-321.
  • 6Sankar R. Paroxysmal disorders. In: Menkes JH, Sarnat HB, Maria BL, eds. Child neurology. 7th ed[M]. Philadelphiaz Lippincott Williams&Wilkins, 2006 : 919-922.
  • 7Patterson JL, Carapetian SA, Hageman JR, et al. Febrile seizures[J]. Pediatr Ann,2013,42(12) :249-254.
  • 8Hu LY, Zou LP, Zhong JM, et al. Febrile seizure recurrence reduced by intermittent oral levetiracetam[J]. Ann Clin Transl Neurol,2014,1(3): 171-179.
  • 9Lynch BA, Lambeng N, Nocka K, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic druglevetiracetam[J]. Proc Natl Acad Sei USA, 2004, 101(26): 9861-9866.
  • 10Nagarkatti N, Deshpande LS, De Lorenzo RJ. Levetiracetam inhibits both ryanodine and IP3 receptor activated calcium induced calcium release in hippocampal neurons in culture[J]. Neurosei Lett, 2008, 436(3): 289-293.

引证文献6

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部